Anthony T Podany
Overview
Explore the profile of Anthony T Podany including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Covington N, Luetkemeyer A, Imperial M, Dawson R, Cramer Y, Rosenkranz S, et al.
Pharmacogenet Genomics
. 2025 Feb;
PMID: 39960813
In Advancing Clinical Therapeutics Globally protocol A5372, a pharmacokinetic study of dolutegravir with 1-month of daily rifapentine/isoniazid, twice-daily dolutegravir offset the induction effects of rifapentine on plasma dolutegravir trough concentrations...
2.
Sunagawa S, Winchester L, Wichman C, Avedissian S, Erikson D, Kernan M, et al.
Contraception
. 2024 Oct;
142():110720.
PMID: 39362338
Objectives: To compare performance characteristics of etonogestrel bioanalytical assays across laboratories. Study Design: We conducted a blinded, six laboratory study: five academic laboratories and one contracted commercial laboratory (reference). Etonogestrel...
3.
Malik J, Modebelu U, Fletcher C, Podany A, Scarsi K, Byrareddy S, et al.
Curr Protoc
. 2024 Jun;
4(6):e1067.
PMID: 38857108
The blood-brain barrier (BBB) constitutes a crucial protective anatomical layer with a microenvironment that tightly controls material transit. Constructing an in vitro BBB model to replicate in vivo features requires...
4.
Avedissian S, Malik J, Podany A, Neely M, Rhodes N, Scarsi K, et al.
Sci Rep
. 2024 May;
14(1):10709.
PMID: 38729980
Three years after SARS-CoV-2 emerged as a global infectious threat, the virus has become endemic. The neurological complications such as depression, anxiety, and other CNS complications after COVID-19 disease are...
5.
Olali A, Wallace J, Gonzalez H, Carpenter K, Patel N, Winchester L, et al.
JBMR Plus
. 2024 Apr;
8(5):ziae037.
PMID: 38590756
Bone mineral density (BMD) loss in people living with HIV occurs with the initiation of combined antiretroviral therapy (cART), particularly with tenofovir disoproxil fumarate (TDF) containing cART. Switching from TDF...
6.
Podany A, Cramer Y, Imperial M, Rosenkranz S, Avihingsanon A, Arduino R, et al.
Clin Infect Dis
. 2024 Apr;
79(4):983-989.
PMID: 38568956
Background: One month of daily rifapentine + isoniazid (1HP) is an effective, ultrashort option for tuberculosis prevention in people with human immunodeficiency virus (HIV). However, rifapentine may decrease antiretroviral drug...
7.
Malik J, Podany A, Khan P, Shaffer C, Siddiqui J, Baranowska-Kortylewicz J, et al.
Cancer Med
. 2023 Nov;
12(23):21075-21096.
PMID: 37997517
Background: Pediatric brain tumors (PBT) stand as the leading cause of cancer-related deaths in children. Chemoradiation protocols have improved survival rates, even for non-resectable tumors. Nonetheless, radiation therapy carries the...
8.
Mykris T, Weinhold J, Winchester L, Scarsi K, Fletcher C, Podany A, et al.
J Chromatogr B Analyt Technol Biomed Life Sci
. 2023 Jul;
1227:123810.
PMID: 37429153
A highly sensitive LC-MS/MS methods were developed and validated to quantify nine antiretrovirals (atazanavir [ATV], tenofovir [TFV], emtricitabine [FTC], darunavir [DRV], dolutegravir [DTG], efavirenz [EFV], lamivudine [3TC], raltegravir [RAL], and...
9.
Agyemang N, Scarsi K, Baker P, Smeaton L, Podany A, Olefsky M, et al.
Pharmacogenet Genomics
. 2023 Jun;
33(6):126-135.
PMID: 37306344
Objective: In AIDS Clinical Trials Group study A5375, a pharmacokinetic trial of levonorgestrel emergency contraception, double-dose levonorgestrel (3 mg, versus standard dose 1.5 mg) offset the induction effects of efavirenz...
10.
Malik J, Acharya A, Avedissian S, Byrareddy S, Fletcher C, Podany A, et al.
Int J Mol Sci
. 2023 May;
24(10.
PMID: 37239978
Angiotensin Converting Enzyme 2 (ACE-2), Transmembrane Serine Protease 2 (TMPRSS-2) and Neuropilin-1 cellular receptors support the entry of SARS-CoV-2 into susceptible human target cells and are characterized at the molecular...